Clinical trial

Imaging Immune Activation in HIV by PET-MR

NCT03684655

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2018-09-21

PhasePHASE2

Study timeline

Study start (actual)2018-09-21Date precision: day

Registry last updated2024-10-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HIV Infectionsunresolved

Interventions

[18F]F-AraG (2'-deoxy-2'-fluoro-9-β-D-arabinofuranosylguanine)DRUG

Sponsors & collaborators

CellSight Technologies, Inc.lead sponsor

National Institute of Allergy and Infectious Diseases (NIAID)collaborator

University of California, San Franciscocollaborator

Mapped research locations

San FranciscoCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03684655 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.